Withdrawn: Erratum
- PMID: 27454363
- PMCID: PMC6986208
- DOI: 10.1210/er.2015-1127.2016.1.test
Withdrawn: Erratum
Retraction in
-
Erratum Notice for Duplicate Publications.Endocr Rev. 2020 Dec 1;41(6):886. doi: 10.1210/endrev/bnaa019. Endocr Rev. 2020. PMID: 32805736 Free PMC article. No abstract available.
Retraction of
-
The Mammalian Blood-Testis Barrier: Its Biology and Regulation.Endocr Rev. 2015 Oct;36(5):564-91. doi: 10.1210/er.2014-1101. Epub 2015 Sep 10. Endocr Rev. 2015. Retraction in: Endocr Rev. 2016 Feb;2016(1):43. doi: 10.1210/er.2015-1127.2016.1.test PMID: 26357922 Free PMC article. Retracted. Review.
Similar articles
-
WITHDRAWN: Erratum.Lancet Oncol. 2012 Apr 24. doi: 10.1016/S1470-2045(12)70175-4. Online ahead of print. Lancet Oncol. 2012. PMID: 22748756
-
WITHDRAWN: Erratum to "Neurobehavioral and genotoxic aspects of rosmarinic acid".Pharmacol Res. 2008 Jul 10. doi: 10.1016/j.phrs.2008.07.001. Online ahead of print. Pharmacol Res. 2008. PMID: 18790653
-
WITHDRAWN: Erratum to "Proton NMR Studies of the NaAlH4 Structure" [J. Magn. Reson. 200 (2009) 280-284].J Magn Reson. 2010 Jun 8. doi: 10.1016/j.jmr.2010.05.010. Online ahead of print. J Magn Reson. 2010. PMID: 20538495
-
Drug-associated cardiovascular risks: A retrospective evaluation of withdrawn drugs.North Clin Istanb. 2018 Sep 5;6(2):196-202. doi: 10.14744/nci.2018.44977. eCollection 2019. North Clin Istanb. 2018. PMID: 31297490 Free PMC article. Review.
-
Withdrawn accelerated approvals for cancer indications in the USA: what is the marketing authorisation status in the EU?Lancet Oncol. 2023 Sep;24(9):e385-e394. doi: 10.1016/S1470-2045(23)00357-1. Lancet Oncol. 2023. PMID: 37657479 Review.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources